maria adriana cataldo

Summary

Affiliation: national institute for infectious diseases
Location: rome, italy
Publications:
1: Cataldo MA, Petrosillo N. Economic considerations of antifungal prophylaxis in
patients undergoing surgical procedures. Ther Clin Risk Manag. 2011 Jan
13;7:13-20. PubMed PMID: ; PubMed Central PMCID: PMC3039009.


2: Cataldo MA, Taglietti F, Petrosillo N. Methicillin-resistant Staphylococcus
aureus: a community health threat. Postgrad Med. 2010 Nov;122(6):16-23. Review.
PubMed PMID: .


3: Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E. Prosthetic joint
infection: recent developments in diagnosis and management. J Infect. 2010
Dec;61(6):443-8. Epub 2010 Oct 7. Review. PubMed PMID: .


4: Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid
screening tests for meticillin-resistant Staphylococcus aureus at hospital
admission: systematic review and meta-analysis. Lancet Infect Dis. 2009
Sep;9(9):546-54. Review. PubMed PMID: .


5: Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, Corti G,
Radice A, Stolzuoli L, Antinori S, Paradisi F, Carosi G, Bernabei R, Antonelli M,
Fadda G, Rossolini GM, Cauda R. Antibiotic usage and risk of colonization and
infection with antibiotic-resistant bacteria: a hospital population-based study.
Antimicrob Agents Chemother. 2009 Oct;53(10):4264-9. Epub 2009 Aug 10. PubMed
PMID: ; PubMed Central PMCID: PMC2764223.


6: Tacconelli E, Cataldo MA. Identifying risk factors for infections: the role of
meta-analyses. Infect Dis Clin North Am. 2009 Jun;23(2):211-24. Review. PubMed
PMID: .


7: Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A,
Antonelli M, Sanguinetti M, Fadda G, Cauda R. Prediction models to identify
hospitalized patients at risk of being colonized or infected with
multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob
Chemother. 2008 Nov;62(5):1130-7. Epub 2008 Jul 17. PubMed PMID: .


8: Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, Fadda
G, Anile C, Maira G, Federico G, Cauda R. Vancomycin versus cefazolin prophylaxis
for cerebrospinal shunt placement in a hospital with a high prevalence of
meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2008 Aug;69(4):337-44.
Epub 2008 Jul 7. PubMed PMID: .


9: Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci (VRE): transmission
and control. Int J Antimicrob Agents. 2008 Feb;31(2):99-106. Epub 2007 Dec 31.
Review. PubMed PMID: .


10: Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic
exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA)
isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008
Jan;61(1):26-38. Epub 2007 Nov 6. Review. PubMed PMID: .


11: Tacconelli E, Cataldo MA. Antimicrobial therapy of Staphylococcus aureus
bloodstream infection. Expert Opin Pharmacother. 2007 Oct;8(15):2505-18. Review.
PubMed PMID: .


12: Tacconelli E, Cataldo MA, De Angelis G, Cauda R. Risk scoring and bloodstream
infections. Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S88-92. Epub 2007 Aug 6.
Review. PubMed PMID: .


13: DAgata EM, Cataldo MA, Cauda R, Tacconelli E. The importance of addressing
multidrug resistance and not assuming single-drug resistance in case-control
studies. Infect Control Hosp Epidemiol. 2006 Jul;27(7):670-4. Epub 2006 Jun 20.
PubMed PMID: .


14: De Bernardis F, Tacconelli E, Mondello F, Cataldo A, Arancia S, Cauda R,
Cassone A. Anti-retroviral therapy with protease inhibitors decreases virulence
enzyme expression in vivo by Candida albicans without selection of avirulent
fungus strains or decreasing their anti-mycotic susceptibility. FEMS Immunol Med
Microbiol. 2004 May 1;41(1):27-34. PubMed PMID: .


15: de Gaetano Donati K, Tumbarello M, Tacconelli E, Bertagnolio S, Rabagliati R,
Scoppettuolo G, Citton R, Cataldo M, Rastrelli E, Fadda G, Cauda R. Impact of
highly active antiretroviral therapy (HAART) on the incidence of bacterial
infections in HIV-infected subjects. J Chemother. 2003 Feb;15(1):60-5. PubMed
PMID: .


16: Tumbarello M, Tacconelli E, de Gaetano Donati K, Bertagnolio S, Cataldo M,
Pirronti T, Ardito F, Cauda R. Nosocomial bacterial pneumonia in human
immunodeficiency virus infected subjects: incidence, risk factors and outcome.
Eur Respir J. 2001 Apr;17(4):636-40. PubMed PMID: .


17: de Gaetano Donati K, Bertagnolio S, Tumbarello M, Tacconelli E, Cataldo M,
Longo B, Cauda R. Effect of highly active antiretroviral therapy on the incidence
of bacterial pneumonia in HIV-infected subjects. Int J Antimicrob Agents. 2000
Nov;16(3):357-60. PubMed PMID: .

Publications

  1. ncbi Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects
    K de Gaetano Donati
    Department of Infectious Diseases, Catholic University, L go A Gemelli, 8, 00168, Rome, Italy
    Int J Antimicrob Agents 16:357-60. 2000
  2. ncbi Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
    Maria Adriana Cataldo
    Second Infectious Diseases Division, National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy
    Ther Clin Risk Manag 7:13-20. 2011
  3. ncbi Methicillin-resistant Staphylococcus aureus: a community health threat
    Maria Adriana Cataldo
    2nd Infectious Diseases Division, National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
    Postgrad Med 122:16-23. 2010
  4. ncbi Prosthetic joint infection: recent developments in diagnosis and management
    Maria Adriana Cataldo
    2nd Infectious Diseases Division, National Institute for Infectious Diseases, Lazzaro Spallanzani, Via Portuense, 29200149 Rome, Italy
    J Infect 61:443-8. 2010
  5. ncbi Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis
    Evelina Tacconelli
    Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
    Lancet Infect Dis 9:546-54. 2009
  6. ncbi Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica del Sacro Cuore, Rome, Italy
    Antimicrob Agents Chemother 53:4264-9. 2009
  7. ncbi Identifying risk factors for infections: the role of meta-analyses
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Roma, Italy
    Infect Dis Clin North Am 23:211-24. 2009
  8. ncbi Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica Sacro Cuore, 00168 Rome, Italy
    J Antimicrob Chemother 62:1130-7. 2008
  9. ncbi Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus
    E Tacconelli
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Hosp Infect 69:337-44. 2008
  10. ncbi Vancomycin-resistant enterococci (VRE): transmission and control
    Evelina Tacconelli
    Division Infectious Diseases, Catholic University, Largo F Vito, 100168, Rome, Italy
    Int J Antimicrob Agents 31:99-106. 2008

Detail Information

Publications18

  1. ncbi Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects
    K de Gaetano Donati
    Department of Infectious Diseases, Catholic University, L go A Gemelli, 8, 00168, Rome, Italy
    Int J Antimicrob Agents 16:357-60. 2000
    ....
  2. ncbi Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
    Maria Adriana Cataldo
    Second Infectious Diseases Division, National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy
    Ther Clin Risk Manag 7:13-20. 2011
    ....
  3. ncbi Methicillin-resistant Staphylococcus aureus: a community health threat
    Maria Adriana Cataldo
    2nd Infectious Diseases Division, National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy
    Postgrad Med 122:16-23. 2010
    ..There are still many unanswered key questions regarding the epidemiology, prevention, and treatment of CA-MRSA infections. This article reviews current knowledge of CA-MRSA...
  4. ncbi Prosthetic joint infection: recent developments in diagnosis and management
    Maria Adriana Cataldo
    2nd Infectious Diseases Division, National Institute for Infectious Diseases, Lazzaro Spallanzani, Via Portuense, 29200149 Rome, Italy
    J Infect 61:443-8. 2010
    ..European networks are needed to define the best diagnostic and treatment strategies in order to reduce future challenge posed by PJIs...
  5. ncbi Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis
    Evelina Tacconelli
    Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
    Lancet Infect Dis 9:546-54. 2009
    ....
  6. ncbi Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica del Sacro Cuore, Rome, Italy
    Antimicrob Agents Chemother 53:4264-9. 2009
    ..Identifying ARB colonization early during antibiotic therapy could target a high-risk hospitalized population that may benefit from intervention to decrease the risk of subsequent nosocomial infections...
  7. ncbi Identifying risk factors for infections: the role of meta-analyses
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Roma, Italy
    Infect Dis Clin North Am 23:211-24. 2009
    ....
  8. ncbi Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex
    Evelina Tacconelli
    Department of Infectious Diseases, Universita Cattolica Sacro Cuore, 00168 Rome, Italy
    J Antimicrob Chemother 62:1130-7. 2008
    ....
  9. ncbi Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus
    E Tacconelli
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Hosp Infect 69:337-44. 2008
    ..02). Our data suggest that use of vancomycin as prophylactic agent for cerebrospinal shunt placement reduces the rate of shunt infections in the context of high prevalence of MRSA...
  10. ncbi Vancomycin-resistant enterococci (VRE): transmission and control
    Evelina Tacconelli
    Division Infectious Diseases, Catholic University, Largo F Vito, 100168, Rome, Italy
    Int J Antimicrob Agents 31:99-106. 2008
    ..Future prospective comparative studies of infection control approaches in different epidemiological situations might be useful...
  11. ncbi Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
    Evelina Tacconelli
    Department of Infectious Diseases, Catholic University, Rome, Italy
    J Antimicrob Chemother 61:26-38. 2008
    ..A systematic review was performed to determine whether antibiotic exposure is a risk factor for the isolation of MRSA...
  12. ncbi Antimicrobial therapy of Staphylococcus aureus bloodstream infection
    Evelina Tacconelli
    Universita Cattolica S Cuore, Istituto Malattie Infettive, Largo F Vito 8, 00168 Roma, Italy
    Expert Opin Pharmacother 8:2505-18. 2007
    ..The review summarises evidence on present therapeutic options for the treatment of S. aureus BSI...
  13. ncbi Risk scoring and bloodstream infections
    Evelina Tacconelli
    Istituto Malattie Infettive, Universita Cattolica S Cuore, Rome, Italy
    Int J Antimicrob Agents 30:S88-92. 2007
    ..New randomised clinical trials are needed to study the efficacy of clinical scores in reducing BSI-associated morbidity and mortality...
  14. ncbi The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studies
    Erika M C D'Agata
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Infect Control Hosp Epidemiol 27:670-4. 2006
    ....
  15. ncbi Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility
    Flavia De Bernardis
    Department of Infectious, Parasitic and Immune Mediated Diseases, Istituto Superiore di Sanita, Viale Regina Elena 299, Rome 00161, Italy
    FEMS Immunol Med Microbiol 41:27-34. 2004
    ..While further demonstrating that HIV-PI inhibit Sap expressions, our results do not support the view that the mentioned inhibition could eliminate Candida or its selection of the oral cavity...
  16. ncbi Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects
    K de Gaetano Donati
    Dept Infectious Diseases, Catholic University, L go A Gemelli 8, 00168 Rome, Italy
    J Chemother 15:60-5. 2003
    ..This study establishes that a significant reduction in bacterial infection incidence occurred in HIV-infected subjects when HAART became the standard therapy for HIV infection...
  17. ncbi Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome
    M Tumbarello
    Dept of Infectious Diseases, Catholic University, Rome, Italy
    Eur Respir J 17:636-40. 2001
    ..Although the incidence of nosocomial bacterial pneumonia, as well of other opportunistic infections, decreased considerably in the era of highly active antiretroviral therapy, it still represents an important cause of mortality...
  18. ncbi Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
    Maria Adriana Cataldo
    2nd Infectious Diseases Division, National Institute for Infectious Diseases, Lazzaro Spallanzani, via Portunse 292, 00149 Rome, Italy
    J Antimicrob Chemother 67:17-24. 2012
    ..To summarize available evidence on the effect of continuous infusion (CoI) of vancomycin compared with intermittent infusion (InI) in adult patients with Gram-positive infections...